WeCanManage. An mHealth Self-management Tool
WeCanManage: An mHealth Self-management Tool to Empower Survivors With Disabilities Due to Long-term Effects of Cancer and Its Treatment
1 other identifier
interventional
20
1 country
1
Brief Summary
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Jul 2024
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2023
CompletedFirst Posted
Study publicly available on registry
December 29, 2023
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedDecember 15, 2025
December 1, 2025
1.1 years
December 15, 2023
December 5, 2025
Conditions
Outcome Measures
Primary Outcomes (13)
Feasibility of WCM app
Evaluate recruitment capability by assessing response rate
1 year
Feasibility of WCM app
Number of participants that started the intervention from consent
1 year
Acceptability of WCM app
Number of participants that adhered to the intervention
1 year
Acceptability of WCM app
Number of participants that were engaged in the intervention
1 year
Acceptability of WCM app
Number of participants that were satisfied with the intervention
1 year
Acceptability of WCM app
Number of participants that found the intervention helpful
1 year
Acceptability of WCM app
Number of participants that wished to continue using the intervention l
1 year
Feasibility with WCM app
Measurement of PROMIS questionnaire, low score health good, high score health not good
Baseline
Feasibility with WCM app
Measurement of PROMIS questionnaire, low score health good, high score health not good
4 Weeks
Feasibility with WCM app
Measurement of PROMIS questionnaire, low score health good, high score health not good
8 Weeks
Feasibility with WCM app
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
Baseline
Feasibility with WCM app
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
4 weeks
Feasibility with WCM app
Measurement of Self Efficacy for managing disease scale questionnaire, low score not confident, high score very confident
8 weeks
Study Arms (1)
WCM app
OTHERWCM app evaluation at baseline, upon completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires
Interventions
WCM app evaluation at baseline, at completion of WCM program and 4 weeks after completion of WCM program, by completing PROMIS and Self Efficacy for managing disease scale questionnaires
Eligibility Criteria
You may qualify if:
- Usability Testing of the WeCanManage High Fidelity Prototype
- Age 18 or older
- Diagnosis of breast cancer, head and neck cancer or sarcoma
- Completion of active treatment
- Self-identify as a person with a disability according to the Americans with Disabilities .Act and the American Community Survey 6-disability questions
- Able to understand and communicate in English
- Medically stable enough to participate in two data collection sessions totaling 2 hours
- Evaluation of the WeCanManage App
- Age 18 or older
- Diagnosis of breast cancer, head and neck cancer or sarcoma
- Completion of primary (i.e. surgery, chemotherapy, and/or radiation); may still be under-going endocrine or hormone therapies
- Self-identify as experiencing disabling after-effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Able to read, understand and communicate in English
- Ownership of a smartphone, tablet, or personal computer.
- Internet access
You may not qualify if:
- Usability Testing of the WeCanManage High Fidelity Prototype
- No diagnosis of breast cancer, head and neck cancer or sarcoma
- In active treatment
- Does not self-identify as a person with a disability according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Not able to understand and communicate in English
- Not medically stable enough to participate in two data collection sessions totaling 2 hours
- Evaluation of the WeCanManage App
- Age 17 or younger
- No diagnosis of breast cancer, head and neck cancer or sarcoma
- In active treatment
- Does not self-identify as experiencing long-term effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions
- Not able to read, understand, and communicate in English
- Does not have access to internet enabled smartphone, tablet, or personal computer
- Does not have access to the internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Illinois at Chicagolead
- Northwestern Universitycollaborator
- Northeastern Illinois Universitycollaborator
Study Sites (1)
University of Illinois
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 15, 2023
First Posted
December 29, 2023
Study Start
July 1, 2024
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
December 15, 2025
Record last verified: 2025-12